Member Info for dan1nat1

UJO not doing bad today, should be our turn soon.

"Faron intends to file these data with regulatory authorities (EMA/FDA) in Q1 2019 and to seek advice on the future clinical development of Traumakine in the EU and the US for this precision treatment."

An update on this could see us break £1 in the short term imo. It maybe this and partner news drop at the same time.

We could get there off the next drill...

I won’t be surprised if we see another RNS this week.

The answer to this from Dec 5th RNS, could be the start of the real game changer.

“Faron intends to file these data with regulatory authorities (EMA/FDA) in Q1 2019 and to seek advice on the future clinical development of Traumakine in the EU and the US for this precision treatment.”

Is that you fundy?

Cyno,

That RNS is only talking about the sub group of patients.

“Now this bit is key. To have the best chance to recover from ARDS you need TRAUMAKINE and the C/T POLYMORPHISM. And actually steroids did NOT effect efficacy in this sub group.”

Best chance of recovery does not mean it will not work in the rest of the population if steroids are taken out of the equation, it just means we have identified a sub group that Traumakine will be most effective in.

Any got to rush new RNS just released...

You are happy to help me?

Yesterday you didn’t realise that steroids did not effect the efficiency of the drug in the sub group of people...which is quite a key point.

Today you still do not acknowledge that Yoda is still important! If steroids have caused the problem and they can prove this then the whole market opens up again, not just the sub group.

“now that they have found that having the specific polymorphism is essential for Traumakine to work.”
Please advise where this has been posted? They have NOT said the mutation in the sub group is essential for it to work. I look forward to your help on this matter.

Looks like our buyer in the background has just taken another £10k’s worth off the table...

Do you think we would be better served as a one trick pony?

“The SP is not helped by the excessive amount of shares in issue.”

If you think the number of shares in issure is more relevant than the market cap maybe you need a new hobby?

Third time you have posted that figure, is that your target entry point by any chance?

You could be right Spike, but it could all be mm games. I wish I knew the time but at one point today possibly around dinner I was dummy selling at 68p...dummy buying 67p to be fair the dummy sells were of a higher value than the buys.

Was that 75k trade not enough for you Spike? ;)

I reckon it was a buy, has probably been being filled since the sp started improving, and is probably the reason the sp started to improve in the first place.

Would be nice to see a few more buys of that volume. £45k is probably more than most pi’s would want in here so hopefully we have some big boys buying in...

Only the buyer knows for sure ;)

I expect they have been filling that for the last few days.

Hi Mani,

I know the original trial should have been completed months ago, but we don’t actually know if they decided to extend it. I was questioning if they would have to let us know that they had, it is after all there money and there trial, admittedly using our drugs under licence.

I know we are expecting these to be inline with the Euro trial, and I have been saying since Yoda was first announced that I expected results from there would be delayed until we get further clarification. But...what’s to actually have stoped our Japanese partners extending there P3 to take into account the Euro results?

The Jap trial was not funded by us, it was part of the licensing deal. Would they even need to release that they had extended the trial? They don’t seemed to have told us that there trial has been completed, and if it’s not completed is it still on going...or as my original thoughts are they just waiting for Yoda to back up any findings.

The move to £1+ could be quick from here, we know there is limited available stock, hopefully those in at the lower 50’s won’t take profits to soon...

Couple of nice buys into close, hopefully we can break 70p next week and the re-rate can begin!

Couple of chunky buys today, I wonder if FIL are adding to there holding?

Q1 so potentially anytime now.